Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview01:25

Glaucoma: Overview

1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Tissue Transplantation01:24

Tissue Transplantation

1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

24
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
24
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

691
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
691

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insulin eye drops for severe refractory chronic ocular graft-versus-host disease.

Bone marrow transplantation·2024
Same author

Adverse environmental conditions are a risk factor for ocular GvHD after allogeneic hematopoietic stem cell transplantation.

Bone marrow transplantation·2020
Same author

[Bilateral ciliary body oedema under treatment with ciclosporine].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2017
Same author

Epidemiology of dry eye disease in Africa: The sparse information, gaps and opportunities.

The ocular surface·2017
Same author

[Ocular Hypotension: How the Retina Surgeon Sees the Causes and Therapeutic Options].

Klinische Monatsblatter fur Augenheilkunde·2016
Same author

[Intraoperative optical coherence tomography in corneal and glaucoma surgical procedures].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2016

Related Experiment Video

Updated: Mar 29, 2026

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
10:29

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Published on: August 29, 2012

16.3K

[Ocular graft-versus-host disease].

T Dietrich-Ntoukas1, P Steven2,3

  • 1Klinik für Augenheilkunde, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Deutschland. tina.dietrich-ntoukas@charite.de.

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|November 26, 2015
PubMed
Summary
This summary is machine-generated.

Ocular graft-versus-host disease (GvHD) after stem cell transplant causes severe dry eye and potential blindness. Early, individualized, multidisciplinary treatment is crucial for managing this inflammatory ocular surface disorder.

Keywords:
Chronic inflammationDry eye diseaseHematopoietic stem cell transplantationKeratoconjunctivitis siccaMoisturizing disorder

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.5K
Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

7.7K

Related Experiment Videos

Last Updated: Mar 29, 2026

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
10:29

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Published on: August 29, 2012

16.3K
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.5K
Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

7.7K

Area of Science:

  • Ophthalmology
  • Hematology
  • Oncology

Background:

  • Ocular graft-versus-host disease (GvHD) is an inflammatory ocular surface disorder with increasing incidence following allogeneic hematopoietic stem cell transplantation (HSCT).
  • This condition significantly impacts quality of life due to dry eye syndromes and can lead to visual impairment and blindness from corneal complications.
  • Ocular GvHD is characterized by severe, therapy-resistant ocular surface dryness and chronic inflammation.

Purpose of the Study:

  • To highlight the challenges in managing ocular GvHD.
  • To emphasize the importance of multimodal, stage-related, and interdisciplinary therapeutic approaches.

Main Methods:

  • Review of current understanding of ocular GvHD pathophysiology and clinical presentation.
  • Discussion of therapeutic strategies and the need for collaboration between ophthalmologists, hematologists, and oncologists.

Main Results:

  • Ocular GvHD presents significant challenges due to its inflammatory nature and resistance to conventional treatments.
  • Corneal complications are a major concern, potentially leading to irreversible vision loss.
  • Effective management requires a comprehensive, individualized approach tailored to disease stage.

Conclusions:

  • Ocular GvHD necessitates prompt diagnosis and management to prevent vision-threatening complications.
  • An interdisciplinary, multimodal therapeutic strategy is essential for optimal patient outcomes.
  • Close collaboration among specialists is key to addressing the complexities of ocular GvHD treatment.